Illumina Inc (ILMN)

  • Get an in-depth profile of Illumina Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

Select Exchange

Symbol Exchange Currency
ILMN NASDAQ USD Real-time ILMN Mexico MXN Delayed 1ILMN Milan EUR Real-time ILMN Frankfurt EUR Delayed ILMN Vienna EUR Real-time
86.320 0.000 (0.00%)
Closed EUR Disclaimer

Illumina Inc Company Profile

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
11530
Equity Type
ORD
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Contact Information
Address
San Diego,92122 United States
Phone
858 202 4500
Fax
858 202 4766
Web
https://www.illumina.com
Top Executives
Name
Age
Since
Title
Stephen P. MacMillan 59 2023 Chairman of the Board
Susan E. Siegel 62 2019 Independent Director
Scott Gottlieb 50 2020 Independent Director
Philip W. Schiller 63 2016 Independent Director
Robert S. Epstein 68 2012 Independent Director
Jacob Thaysen 48 2023 CEO & Director
Gary S. Guthart 57 2017 Independent Director
Scott B. Ullem 56 2023 Director

Customize

Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.